Explore the latest developments concerning Pfizer (PFE) Stock.
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Pfizer (PFE) closed at $23.72, marking a -2.47% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.72%. Meanwhile, the Dow experienced a rise of 0.3%, and the technology-dominated Nasdaq saw an increase of 1.12%.
The drugmaker's shares have seen a decrease of 6.61% over the last month, not keeping up with the Medical sector's gain of 12.48% and the S&P 500's loss of 0.9%.
The investment community will be paying close attention to the earnings performance of Pfizer in its upcoming release. The company is slated to reveal its earnings on August 4, 2026. On that day, Pfizer is projected to report earnings of $0.68 per share, which would represent a year-over-year decline of 12.82%. In the meantime, our current consensus estimate forecasts the revenue to be $14.48 billion, indicating a 1.2% decline compared to the corresponding quarter of the prior year.
Pfizer's Growth Story Faces a Wait as Pipeline and Leadership Doubts Mount
Analysts Rajesh Kumar and Dylan Whitfield downgraded to Hold from Buy and lowered their target forecast to $28 from $32, citing increased uncertainty around key pipeline assets and recent executive leadership changes.
The original bullish thesis centered on Pfizer’s increased R&D focus, a dividend yield of roughly 6%, and management’s goal of delivering high single-digit revenue growth between 2028 and 2032.
However, HSBC analysts now believe those growth expectations are unlikely to be validated in the near term.
A key factor behind the downgrade was a reduction in the probability of success for sigvotatug vedotin (SV) to 40% following its Phase 3 setback in non-small cell lung cancer (NSCLC).
613 Blonde Body Wave 13×6 HD Lace Frontal 100 Human Hair Wigs 30 36 Inch Honey Colored Lace Closure Front Wig for Black Women
The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.
For more detailed information, explore updates concerning Pfizer (PFE) Stock.
0 Comments